Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Legislation

Latest From Legislation

340B Reform: US House Bills Mark The End Of The Beginning

Energy & Commerce Health Subcommittee releases several discussion drafts at hearing on 340B drug discount program reform as the debate seems poised to move into the next phase.

Pricing Debate Legislation

EU Survey Shows Wide Variations In How Countries Deal With Drug Shortages

A survey of EU member states has shown wide variations in the way that they deal with shortages and discontinuation of medicines.

Distribution Compliance

US Senators Seek 'Clarity’ On Middlemen Obstructing List Price Reductions

Letters to several pharmacy benefit managers and wholesalers request information on whether middlemen have discouraged decrease in list prices.
Pricing Debate Legislation

A Tamer 'Wildcard'? Antibiotic Exclusivity Would Have More Strings Attached In New Bill

Advocates for antibiotic incentives are hoping to attach 'wildcard' patent proposal to pending PAHPA reauthorization bill; New conditions on exclusivity are intended to make approach more politically viable – and assure favorable CBO score.
Legislation Intellectual Property

BIA Wants More Brexit Clarity From UK Regulator As Odds Narrow On ‘No-Deal’ Outcome

The BioIndustry Association is concerned about the lack of clarity on future UK-EU drug regulation after EU heads of state failed to make any tangible progress on Brexit at their much heralded end-of-June summit.

Brexit United Kingdom

Australian Medicines Shortages Bill Outlines 'Critical Impact' Criteria

Legislation that would introduce the proposed mandatory scheme for reporting medicines shortages has come before the Australian parliament. Among other things it specifies which shortages would have a "critical impact" on patient health.

Australia Distribution
See All